名創優品紐約開設旗艦店 料美國分店數目增近一倍
名創優品(MNSO.US)今年將在紐約開設一間旗艦店,並將美國分店數量增加近一倍,
名創優品負責海外業務的副總裁Vincent Huang向《路透社》表示,由於美國經濟在疫情重創下租金下跌,令在美國擴張的成本下降約20%,認爲目前美國市場有開設數千間分店的潛力。
他稱,公司目前在全球90多個國家擁有約4,800間分店,預計到今年底在美國的分店數量將從年初的30間增加到54間,而公司在美國的銷售額已恢復到疫情前的水平,今年上半年收入按年增長73%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.